Loading...
XNASLMAT
Market cap2.10bUSD
Jan 10, Last price  
93.59USD
1D
-1.38%
1Q
3.31%
Jan 2017
269.34%
IPO
1,351.01%
Name

LeMaitre Vascular Inc

Chart & Performance

D1W1MN
XNAS:LMAT chart
P/E
69.90
P/S
10.88
EPS
1.34
Div Yield, %
0.59%
Shrs. gr., 5y
2.07%
Rev. gr., 5y
12.88%
Revenues
193m
+19.69%
26,183,00030,727,00034,628,00041,446,00048,720,00050,908,00056,060,00057,685,00056,735,00064,549,00071,097,00078,352,00089,151,000100,867,000105,568,000117,232,000129,366,000154,424,000161,651,000193,484,000
Net income
30m
+45.89%
927,00055,000-1,172,000-2,934,000-3,314,0001,598,0006,013,0002,143,0002,571,0003,202,0003,915,0007,758,00010,590,00017,177,00022,943,00017,934,00021,220,00026,907,00020,636,00030,105,000
CFO
37m
+44.81%
1,682,000-1,202,000-526,000-1,826,000581,0005,440,0007,052,0003,170,0004,722,0005,388,0005,512,00011,438,00016,896,00022,868,00019,506,00014,179,00034,800,00035,102,00025,378,00036,751,000
Dividend
Aug 15, 20240.16 USD/sh
Earnings
Feb 25, 2025

Profile

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
IPO date
Oct 19, 2006
Employees
591
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
193,484
19.69%
161,651
4.68%
Cost of revenue
156,287
131,715
Unusual Expense (Income)
NOPBT
37,197
29,936
NOPBT Margin
19.22%
18.52%
Operating Taxes
9,370
6,854
Tax Rate
25.19%
22.90%
NOPAT
27,827
23,082
Net income
30,105
45.89%
20,636
-23.31%
Dividends
(12,448)
(10,988)
Dividend yield
0.98%
1.08%
Proceeds from repurchase of equity
5,317
2,824
BB yield
-0.42%
-0.28%
Debt
Debt current
4,942
1,886
Long-term debt
35,719
31,306
Deferred revenue
Other long-term liabilities
2,268
2,167
Net debt
(64,413)
(49,499)
Cash flow
Cash from operating activities
36,751
25,378
CAPEX
(7,265)
(3,229)
Cash from investing activities
(24,715)
(10,371)
Cash from financing activities
(7,131)
(9,234)
FCF
12,203
16,059
Balance
Cash
105,074
82,691
Long term investments
Excess cash
95,400
74,608
Stockholders' equity
111,044
91,979
Invested Capital
226,334
201,137
ROIC
13.02%
11.52%
ROCE
11.56%
10.85%
EV
Common stock shares outstanding
22,423
22,171
Price
56.76
23.34%
46.02
-8.38%
Market cap
1,272,729
24.74%
1,020,309
-5.41%
EV
1,208,316
970,810
EBITDA
46,712
39,369
EV/EBITDA
25.87
24.66
Interest
986
Interest/NOPBT
3.29%